author-photo

Delphine Hennicken

Bristol-Myers Squibb

18

Papers

1580

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Safety of weight-based dosing of nivolumab with or without ipilimumab by body mass index (BMI) stratified by sex across 14 CheckMate clinical trials.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
308 Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A phase 3, open-label, randomized study of nivolumab plus ipilimumab or standard of care (SOC) versus SOC alone in patients (pts) with previously untreated unresectable or metastatic urothelial carcinoma (mUC; CheckMate 901).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: A randomised, double-blind, multicentre, phase 3 trial

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (261)
Overall survival (OS) and safety results from a phase 3 trial of ipilimumab (IPI) at 3 mg/kg vs 10 mg/kg in patients with metastatic melanoma (MEL)

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (15)
Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression: Results From 2 Randomized, Double-Blind Studies.

2015 Journal of Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (10)
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders

2015 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (33)
821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results

2014 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

2013 BMC Medicine
Show All
- Source
- Cite
- Save
Citations (228)